Court Orders Rs 3.4 Lakh Payout for Bariatric Surgery

Published On 2025-02-24 12:00 GMT   |   Update On 2025-02-24 12:01 GMT

Surat: Signifying that an insurer cannot deny mediclaims without concrete evidence of pre-existing treatment, the Surat Consumer Disputes Redressal Commission (Additional) has directed an insurance company to reimburse around Rs 3.4 lakh for a 42-year-old policyholder's weight-loss surgery, which the company had previously denied.

The patient, a resident of Dabholi, Surat, underwent bariatric surgery for morbid obesity from January 27, 2022, to February 1, 2022, at a private hospital. He paid Rs 3,39,691 for the procedure and subsequently filed a claim under his Rs 5 lakh floater mediclaim policy, which was valid from August 24, 2021, to August 23, 2022. The patient as a policyholder maintained continuous health insurance coverage since 2010.

For more information, click on the link below:

Bariatric Surgery Claim Rejection Overturned! Court Orders Rs 3.4 Lakh Payout

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News